Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with...

por Drew, Yvette, Ledermann, Jonathan, Hall, Geoff, Rea, Daniel, Glasspool, Ros, Highley, Martin, Jayson, Gordon, Sludden, Julieann, Murray, James, Jamieson, David, Halford, Sarah, Acton, Gary, Backholer, Zoe, Mangano, Raffaella, Boddy, Alan, Curtin, Nicola, Plummer, Ruth
Publicado 2016

Comment on ‘The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome': Intraperitoneal FOLFOX does not consistently...

por Lentschener, Claude, Nicco, Carole, Terris, Benoit, Samama, Charles-Marc, Coriat, Romain
Publicado 2016

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

por Miyamoto, M, Takano, M, Iwaya, K, Shinomiya, N, Goto, T, Kato, M, Suzuki, A, Aoyama, T, Hitrata, J, Nagaoka, I, Tsuda, H, Furuya, K
Publicado 2017

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis

por White, N M A, Masui, O, Newsted, D, Scorilas, A, Romaschin, A D, Bjarnason, G A, Siu, K W M, Yousef, G M
Publicado 2017

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer

por MacLeod, A Kenneth, Acosta-Jimenez, Lourdes, Coates, Philip J, McMahon, Michael, Carey, Frank A, Honda, Tadashi, Hayes, John D, Henderson, Colin J, Wolf, C Roland
Publicado 2017

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

por Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Publicado 2018

Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system’

por Tapial, Sandra, Rueda, Daniel, Arriba, María, Luis García, Juan, Brandáriz, Lorena, Pérez, Jessica, Rodríguez, Yolanda, García-Olmo, Damián, González-Sarmiento, Rogelio, Urioste, Miguel, Perea, José
Publicado 2018

Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study

por Trudel-Fitzgerald, Claudia, Zhou, Eric S, Poole, Elizabeth M, Zhang, Xuehong, Michels, Karin B, Eliassen, A Heather, Chen, Wendy Y, Holmes, Michelle D, Tworoger, Shelley S, Schernhammer, Eva S
Publicado 2018

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

por Hottinger, A F, Ben Aissa, A, Espeli, V, Squiban, D, Dunkel, N, Vargas, M I, Hundsberger, T, Mach, N, Schaller, K, Weber, D C, Bodmer, A, Dietrich, P-Y
Publicado 2018

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

por Linton, A, Cheng, Y Y, Griggs, K, Schedlich, L, Kirschner, M B, Gattani, S, Srikaran, S, Chuan-Hao Kao, S, McCaughan, B C, Klebe, S, van Zandwijk, N, Reid, G
Publicado 2018

Population attributable fractions continue to unmask the power of prevention

por Bray, Freddie, Soerjomataram, Isabelle
Publicado 2018

When it comes to genomic analysis of tumours, don't buy in bulk

por Nieva, Jorge, Hicks, James
Publicado 2018

The growing importance of radiation worker studies

por Wakeford, Richard
Publicado 2018

Desperately seeking…Models to find the right partner and the best use for checkpoint inhibitors

por Bertolini, Francesco
Publicado 2018

Secondary KIT mutations: the GIST of drug resistance and sensitivity

por Napolitano, Andrea, Vincenzi, Bruno
Publicado 2019

A growing link—what is the role of height in cancer risk?

por Giovannucci, Edward
Publicado 2019

Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis"

por Péré, Hélène, Pavie, Juliette, Pernot, Simon, Veyer, David, Bertaud, Dominique, Hurel, Sophie, Bélec, Laurent, Hans, Stéphane, Ménard, Madeleine, Cochand-Priollet, Béatrix, Weiss, Laurence, Bats, Anne-Sophie, Badoual, Cécile
Publicado 2019

A NOTCH added to metabolomics

por Brustugun, Odd Terje
Publicado 2019

New survival standards for advanced melanoma

por Spain, Lavinia, Larkin, James, Turajlic, Samra
Publicado 2020

COVID-19 and cancer research

por Harris, Adrian L.
Publicado 2020